Mountain View, CA, United States of America

Thomas G Goff

This inventor holds 33 USPTO granted patents and 9 published patent applications, plus 3 CIPO patents and 2 EPO patents, primarily in Sleep Apnea Devices. Top assignees: Shockwave Medical, Inc., Hancock Medical, Inc., Kerberos Proximal Solutions, Inc.. Active years: 2004-2026.

USPTO Granted Patents = 33 

% Patents Active = 84.8


 

Average Co-Inventor Count = 2.6

ph-index = 18

Forward Citations = 1,495(Granted Patents)


Location History:

  • Menlo Park, CA (US) (2004 - 2013)
  • Mountain View, CA (US) (2006 - 2023)

Company Filing History:


Years Active: 2004-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Shock Wave Balloon Catheter
Portable PAP Device
Positional Obstructive Sleep Apnea
Shock Wave Valvuloplasty
Positive Airway Pressure
Intermittent Positive Airway Pressure
Fluid Exchange System
Embolization Protection
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Thomas G. Goff

Introduction: Thomas G. Goff is a pioneering inventor based in Mountain View, California, known for his groundbreaking contributions to various technological fields.

Latest Patents: Thomas G. Goff holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Thomas G. Goff has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Thomas G. Goff has collaborated with top engineers, scientists, and researchers, fostering a culture of innovation and excellence in all his projects.

Conclusion: Thomas G. Goff's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true visionary in the world of inventions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…